Some studies have found excellent sensitivities (> 90%) and satisfactory specificities (> 80%), indicating NGAL as a useful marker for both including and excluding the diagnosis of type I CRS (29, 30). This evidence concerns the gene LCN2 and congenital rubella syndrome.